← Back
$IOVA All transactions

IOVANCE BIOTHERAPEUTICS, INC.

F

$ Value

$8K

Shares

4,464

Price

$2

Filed

Jun 4

Insider

Name

Bellemin Jean-Marc

Title

Chief Financial Officer

CIK

0001754253

Roles

Officer

Transaction Details

Transaction Date

2025-06-02

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

60,529

Footnotes

Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. | Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan. | Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. | Represents common stock remaining after deducting the common stock withheld for taxes. | Each RSU represents a contingent right to receive one share of the Issuer's common stock. | The remaining RSUs will vest in equal quarterly installments. | Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Filing Info

Accession No.

0001104659-25-056432

Form Type

4

Issuer CIK

0001425205

Bellemin Jean-Marc's History

Date Ticker Type Value
2025-06-02 IOVA M $0
2025-06-02 IOVA F $8K
2025-06-02 IOVA M $0

Other Insiders at IOVA (90d)

Insider Bought Sold Last
BILINSKY IGOR
Chief Operating Officer
2026-03-05
Vogt Frederick G
Interim CEO & General Counsel
2026-03-05
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
2026-03-05
Puri Raj K.
Chief Regulatory Officer
2026-03-05
Kirby Daniel Gordon
Chief Commercial Officer
2026-02-24